Bataller R, Brenner DA (2005): Liver fibrosis. J Clin Invest 115, 209-218.
Bechtel W, Zeisberg M (2009): Bone Morphogenic Protein-7 (BMP7) and the kidneys: insights into the future anagement of chronic kidney diseases. Dtsch Med Wochenschr 134, 1688-1691.
Beck HN, Drahushuk K, Jacoby DB, Higgins D, Lein PJ (2001): Bone morphogenetic protein-5 (BMP-5) promotes dendritic growth in cultured sympathetic neurons. BMC Neurosci 2, 12.
Bhardwaj A, Sethi G, Vadhan-Raj S, Bueso-Ramos C, Takada Y, Gaur U, Nair AS, Shishodia S, Aggarwal BB (2007): Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kappaB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells. Blood 109, 2293-2302.
Biyikli NK, Tugtepe H, Cakalagaoglu F, Ilki A, Alpay H (2005): Downregulation of the expression of bone morphogenetic protein 7 in experimental pyelonephritis. Pediatr Nephrol 20, 1230-1236.
Bohle A, Christ H, Grund KE, Mackensen S (1979): The role of the interstitium of the renal cortex in renal disease. Contrib Nephrol 16, 109-114.
Border WA, Noble NA (1994): Transforming growth factor beta in tissue fibrosis. New Engl J Med 331, 1286-1292.
Bradford MM (1976): A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248-254.
Bramlage CP, Müller GA (2010): Bone Morphogenetic Protein-7 (BMP-7). Der Nephrologe 6, 528-530.
Bramlage CP, Tampe B, Koziolek M, Maatouk I, Bevanda J, Bramlage P, Ahrens K, Lange K, Schmid H, Cohen CD, Kretzler M, Müller GA (2010): Bone Morphogenetic Protein (BMP)-7 expression is decreased in human hypertensive nephrosclerosis. BMC Nephrol 11, 31.
Bramlage CP, Müller GA, Tampe B, Bevanda J, Maatouk I, Koziolek M, Lange K, Ahrens K, Schmid H, Cohen CD, Bramlage P, Kretzler M, Strutz F (2011): The role of bone morphogenetic protein-5 (BMP-5) in human nephrosclerosis. J Nephrol 24, 647-655.
Burns WC, Velkoska E, Dean R, Burrell LM, Thomas MC (2010): Angiotensin II mediates epithelial-to-mesenchymal transformation in tubular cells by ANG 1-7/MAS-1-dependent pathways. Am J Physiol Renal Physiol 299, 585-593.
Celeste AJ, Iannazzi JA, Taylor RC, Hewick RM, Rosen V, Wang EA, Wozney JM (1990):
Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci 87, 9843-9847.
Chien A, Edgar DB, and Trela JM (1976): Deoxyribonucleic acid polymerase from the extreme thermophile Thermus aquaticus. J Bacteriol 127, 1550-1557.
Chomczynski P, Sacchi N (1987): Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162, 156-159.
Chuang MJ, Sun KH, Tang SJ, Deng MW, Wu YH, Sung JS, Cha TL, Sun GH (2008): Tumor-derived tumor necrosis factor-alpha promotes progression and epithelial-mesenchymal transition in renal cell carcinoma cells. Cancer Sci 99, 905-913.
Cui X, Zhou J, Qiu J, Johnson MR, Mrug M (2009): Validation of endogenous internal real-time PCR controls in renal tissues. Am J Nephrol 30, 413-417.
Dai Q, Xu M, Yao M, Sun B (2007): Angiotensin AT1 receptor antagonists exert anti-inflammatory effects in spontaneously hypertensive rats. Br J Pharmacol 152, 1042-1048.
Derynck R, Gelbart WM, Harland RM, Heldin CH, Kern SE, Massagué J, Melton DA, Mlodzik M, Padgett RW, Roberts AB, Smith J, Thomsen GH, Vogelstein B, Wang XF (1996): Nomenclature:
vertebrate mediators of TGFbeta family signals. Cell 87, 173.
Donnahoo KK, Meng X, Ayala A, Cain MP, Harken AH, Meldrum DR (1999): Early kidney TNF-alpha expression mediates neutrophil infiltration and injury after renal ischemia-reperfusion. Am J Physiol 277, 922-929.
Ducy P, Karsenty G (2000): The family of bone morphogenetic proteins. Kidney Int 57, 2207-2214.
Dudas PL, Argentieri RL, Farrell FX (2009): BMP-7 fails to attenuate TGF-beta1-induced epithelial-to-mesenchymal transition in human proximal tubule epithelial cells. Nephrol Dial Transplant 24, 1406-1416.
Dudley AT, Robertson EJ (1997): Overlapping expression domains of bone morphogenetic protein family members potentially account for limited tissue defects in BMP7 deficient embryos. Dev Dyn 208, 349-362.
Dudley AT, Lyons KM, Robertson EJ (1995): A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev 9, 2795-807.
Ebner R, Chen RH, Lawler S, Zioncheck T, Derynck R (1993): Determination of type I receptor specificity by the type II receptors for TGF-beta or activin. Science 262, 900-902.
Eknoyan G, Lameire N, Barsoum R, Eckardt KU, Levin A, Levin N, Locatelli F, MacLeod A, Vanholder R, Walker R, Wang H (2004): The burden of kidney disease: improving global outcomes. Kidney Int 66, 1310-1314.
Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S (1998): A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391, 43-50.
Floege J, Grone HJ (1995): Progression of renal failure: what ist he role of cytokines? Nephrol Dial Transplant 10, 1575-1586.
Frei U, Schober-Halstenberg HJ (2008): Nierenersatztherapie in Deutschland, Bericht über Dialysebehandlung und Nierentransplantation in Deutschland 2006/2007, QUASI Niere.
Godin RE, Robertson EJ, Dudley AT (1999): Role of BMP family members during kidney development. Int J Dev Biol 43, 405-411.
Gould SE, Day M, Jones SS, Dorai H (2002): BMP-7 regulates chemokine, cytokine, and hemodynamic gene expression in proximal tubule cells. Kidney Int 61, 51-60.
Guijarro C, Egido J (2001): Transcription factor-kappa B (NF-kappa B) and renal disease. Kidney Int 59, 415-424.
Heldin CH, Miyazono K, ten Dijke P (1997): TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 390, 465-471.
Higuchi R, Dollinger G, Walsh PS, Griffith R (1992): Simultaneous amplification and detection of specific DNA sequences. Biotechnology 10, 413-417.
Hogan BL (1996): Bone morphogenetic proteins in development. Curr Opin Genet Dev 6, 432-438.
Holdsworth SR, Summers SA (2008): Role of mast cells in progressive renal diseases. J Am Soc Nephrol 19, 2254-2261.
Hsu CY, Iribarren C, McCulloch CE, Darbinian J, Go AS (2009): Risk factors for end-stage renal disease: 25-year follow-up. Arch Intern Med 169, 342-350.
Hugo C (2003): The thrombospondin 1-TGF-beta axis in fibrotiv renal disease. Nephrol Dial Transplant 18, 1241-1245.
Jaroszewski L, Rychlewski L, Li Z, Li W, Godzik A (2005): FFAS03: a server for profile--profile sequence alignments. Nucleic Acids Res 33, 284-288.
John R, Nelson PJ (2007): Dendritic cells in the kidney. J Am Soc Nephrol 18, 2628-2635.
Johnsen IK, Kappler R, Auernhammer CJ, Beuschlein F (2009): Bone morphogenetic proteins 2 and 5 are down-regulated in adrenocortical carcinoma and modulate adrenal cell proliferation and steroidogenesis. Cancer Res 69, 5784-5792.
Johnson RJ, Alpers CE, Yoshimura A, Lombardi D, Pritzl P, Floege J, Schwartz SM (1992): Renal injury from angiotensin II-mediated hypertension. Hypertension 19, 464-474.
Jones CL, Buch S, Post M, McCulloch L, Liu E, Eddy AA (1992): Renal extracellular matrix accumulation in acute puromycin aminonucleoside nephrosis in rats. Am J Pathol 141, 1381-1396.
Juncos LA, Garvin J, Carretero OA und Ito S (1995): Flow modulates myogenic responses in isolated microperfused rabbit afferent arterioles via endothelium-derived nitric oxide. J Clin Invest 95, 2741-2748.
Kagami S, Border WA, Miller DE, Noble NA (1994): Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J Clin Invest 93, 2431-2437.
Kalluri R, Weinberg RA (2009): The basics of epithelial-mesenchymal transition. J Clin Invest 119, 1420-1428.
Kangsamaksin T, Morris RJ (2011): Bone morphogenetic protein 5 regulates the number of keratinocyte stem cells from the skin of mice. J Invest Dermatol 131, 580-585.
Kazama I, Mahoney Z, Miner JH, Graf D, Economides AN, Kreidberg JA (2008): Podocyte-derived BMP7 is critical for nephron development. J Am Soc Nephrol 19, 2181-2191.
Khan SB, Cook HT, Bhangal G, Smith J, Tam FW, Pusey CD (2005): Antibody blockade of TNF-alpha reduces inflammation and scarring in experimental crescentic glomerulonephritis. Kidney Int 67, 1812-1820.
King JA, Marker PC, Seung KJ, Kingsley DM (1994): BMP5 and the molecular, skeletal, and soft-tissue alterations in short ear mice. Dev Biol 166, 112-122.
Kingsley DM, Bland AE, Grubber JM, Marker PC, Russell LB, Copeland NG, Jenkins NA (1992): The mouse short ear skeletal morphogenesis locus is associated with defects in a bone morphogenetic member of the TGF beta superfamily. Cell 71, 399-410.
Kitten AM, Kreisberg JI, Olson MS (1999): Expression of osteogenic protein-1 mRNA in cultured kidney cells. J Cell Physiol 181, 410-415.
Klahr S (2003): The bone morphogenetic proteins (BMPs). Their role in renal fibrosis and renal function. J Nephrol 16, 179-185.
Klahr S, Morrissey J (1998): Angiotensin II and gene expression in the kidney. Am J Kidney Dis 31, 171-176.
Kondo S, Kagami S, Kido H, Strutz F, Muller GA und Kuroda Y (2001): Role of mast cell tryptase in renal interstitial fibrosis. J Am Soc Nephrol 12, 1668-76.
Kopp JB, Factor VM, Mozes M, Nagy P, Sanderson N, Bottinger EP, Klotman PE und Thorgeirsson SS (1996): Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease. Lab Invest 74, 991-1003.
Krensky AM, Ahn YT (2007): Mechanisms of disease: regulation of RANTES (CCL5) in renal disease.
Nat Clin Pract Nephrol 3, 164-170.
Kuncio GS, Neilson EG, Haverty T (1991): Mechanisms of tubulointerstitial fibrosis. Kidney Int 39, 550-556.
Laemmli UK (1970): Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
Lange-Sperandio B, Trautmann A, Eickelberg O, Jayachandran A, Oberle S, Schmidutz F, Rodenbeck B, Hömme M, Horuk R, Schaefer F (2007): Leukocytes induce epithelial to mesenchymal transition after unilateral ureteral obstruction in neonatal mice. Am J Pathol 171, 861-871.
Lee SB, Kalluri R (2010): Mechanistic connection between inflammation and fibrosis. Kidney Int 119, 22-26.
Leonard EJ, Yoshimura T (1990): Human monocyte chemoattractant protein-1 (MCP-1). Immunol Today 11, 97-101.
Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC, Altieri DC (1998): Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396, 580-584.
Lin LF, Doherty DH, Lile JD, Bektesh S, Collins F (1993): GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260, 1130-1132.
Liu X, Zou H, Slaughter C, Wang X (1997): DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 89, 175-184.
Luo G, Hofmann C, Bronckers AL, Sohocki M, Bradley A, Karsenty G (1995): BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev 9, 2808-2820.
Luster AD (1998): Chemokines--chemotactic cytokines that mediate inflammation. N Engl J Med 338, 436-45.
Maric I, Poljak L, Zoricic S, Bobinac D, Bosukonda D, Sampath KT, Vukicevic S (2003): Bone morphogenetic protein-7 reduces the severity of colon tissue damage and accelerates the healing of inflammatory bowel disease in rats. J Cell Physiol 196, 258-264.
Massagué J (1990): The transforming growth factor-beta family. Annu Rev Cell Biol 6, 597-641.
Massagué J (1992): Receptors for the TGF-beta family. Cell 69, 1067-1070.
Meno C, Saijoh Y, Fujii H, Ikeda M, Yokoyama T, Yokoyama M, Toyoda Y, Hamada H (1996): Left-right asymmetric expression of the TGF beta-family member lefty in mouse embryos. Nature 381, 151-155.
Mitu G, Hirschberg R (2008): Bone morphogenetic protein-7 (BMP7) in chronic kidney disease. Front Biosci 13, 4726-4739.
Moses HL, Yang EY, Pietenpol JA (1990): TGF-beta stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 63, 245-247.
Motazed R, Colville-Nash P, Kwan JT, Dockrell ME (2008): BMP-7 and proximal tubule epithelial cells:
activation of multiple signaling pathways reveals a novel anti-fibrotic mechanism. Pharm Res 25, 2440-2446.
Müller GA, Markovic-Lipkovski J, Frank J und Rodemann HP (1992): The role of interstitial cells in the progression of renal diseases. J Am Soc Nephrol 2, 198-205.
Mullis KB, Faloona FA (1987): Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods Enzymol 155, 335-350.
Nelson PJ, Kim HT, Manning WC, Goralski TJ, Krensky AM (1993): Genomic organization and transcriptional regulation of the RANTES chemokine gene. J Immunol 151, 2601-2612.
Ng YY, Huang TP, Yang WC, Chen ZP, Yang AH, Mu W, Nikolic-Paterson DJ, Atkins RC, Lan HY (1998): Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats. Kidney Int 54, 864-876.
Norton JD (2000): ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis. J Cell Sci 113, 3897-3905.
Orth K, Chinnaiyan AM, Garg M, Froelich CJ, Dixit VM (1996): The CED-3/ICE-like protease Mch2 is activated during apoptosis and cleaves the death substrate lamin A. J Biol Chem 271, 16443-16446.
Oxburgh L, Dudley AT, Godin RE, Koonce CH, Islam A, Anderson DC, Bikoff EK, Robertson EJ (2005): BMP4 substitutes for loss of BMP7 during kidney development. Dev Biol 286, 637-46.
Ozkaynak E, Rueger DC, Drier EA, Corbett C, Ridge RJ, Sampath TK und Oppermann H (1990): OP-1 cDNA encodes an osteogenic protein in the TGF-beta family. EMBO J 9, 2085-2093.
Ozkaynak E, Schnegelsberg PN, Oppermann H (1991): Murine osteogenic protein (OP-1): high levels of mRNA in kidney. Biochem Biophys Res Commun 179, 116–123.
Ozkaynak E, Schnegelsberg PN, Jin DF, Clifford GM, Warren FD, Drier EA, Oppermann H (1992):
Osteogenic protein-2. A new member of the transforming growth factor-beta superfamily expressed early in embryogenesis. J Biol Chem 267, 25220-25227.
Panzer U, Steinmetz OM, Stahl RA, Wolf G (2006): Kidney diseases and chemokines. Current Drug Targets 54, 1570-1580.
Peters H, Border WA, Noble NA (1998): Targeting TGF-beta overexpression in renal disease:
maximizing the antifibrotic action of angiotensin II blockade. Kidney Int 54, 1570-1580.
Piscione TD, Yager TD, Gupta IR, Grinfeld B, Pei Y, Attisano L, Wrana JL, Rosenblum ND (1997):
BMP-2 and OP-1 exert direct and opposite effects on renal branching morphogenesis. Am J Physiol 273, 961-975.
Radonic A, Thulke S, Mackay IM, Landt O, Siegert W, Nitsche A (2004): Guideline to reference gene selection for quantitative real-time PCR. Biochem Biophys Res Commun 313, 856-862.
Riccioni G, Vitulano N, Zanasi A, Bellocci F und d'Orazio N (2010): Aliskiren: beyond blood pressure reduction. Expert Opin Investig Drugs 19, 1265-1274.
Rollins BJ, Walz A, Baggiolini M (1991): Recombinant human MCP-1/JE induces chemotaxis, calcium flux, and the respiratory burst in human monocytes. Blood 78, 1112-1116.
Rovin BH, Dickerson JA, Tan LC, Hebert CA (1995): Activation of nuclear factor-kappa B correlates with MCP-1 expression by human mesangial cells. Kidney Int 48, 1263-1271.
Rudnicki M, Eder S, Perco P, Enrich J, Scheiber K, Koppelstätter C, Schratzberger G, Mayer B, Oberbauer R, Meyer TW, Mayer G (2007): Gene expression profiles of human proximal tubular epithelial cells in proteinuric nephropathies. Kidney Int 71, 325-335.
Ruiz-Ortega M und Egido J (1997): Angiotensin II modulates cell growth-related events and synthesis of matrix proteins in renal interstitial fibroblasts. Kidney Int 52, 1497-1510.
Ruiz-Ortega M, Rupérez M, Esteban V, Rodríguez-Vita J, Sánchez-López E, Carvajal G, Egido J (2006): Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases.
Nephrol Dial Transplant 21, 16-20.
Ryan M, Johnson G, Kirk J, Fuerstenberg S, Zager R, Torok-Storb B (1994): HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int 45, 48-57.
Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA (1988): Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239, 487-491.
Sampath TK, Maliakal JC, Hauschka PV, Jones WK, Sasak H, Tucker RF, White KH, Coughlin JE, Tucker MM, Pang RH, Corbett C, Özkaynak E, Oppermann H, Rueger DC (1992): Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J Biol Chem 267, 20352-20362.
Schaefer L, Macakova K, Raslik I, Micegova M, Gröne HJ, Schönherr E, Robenek H, Echtermeyer FG, Grässel S, Bruckner P, Schaefer RM, Iozzo RV, Kresse H (2002): Absence of decorin adversely influences tubulointerstitial fibrosis of the obstructed kidney by enhanced apoptosis and increased inflammatory reaction. Am J Pathol 160, 1181-1191.
Schall TJ, Bacon K, Toy KJ, Goeddel DV (1990): Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 347, 669-671.
Sean Eardley K, Cockwell P (2005): Macrophages and progressive tubulointerstitial disease. Kidney Int 68, 437-455.
Segerer S, Nelson PJ, Schlöndorff D (2000): Chemokines, chemokine receptors, and renal disease:
from basic science to pathophysiologic and therapeutic studies. J Am Soc Nephrol 11, 152-176.
Sikder HA, Devlin MK, Dunlap S, Ryu B, and Alani RM (2003): Id proteins in cell growth and tumorigenesis. Cancer Cell 3, 525-530.
Simon M, Maresh JG, Harris SE, Hernandez JD, Arar M, Olson MS, Abboud HE (1999): Expression of bone morphogenetic protein-7 mRNA in normal and ischemic adult rat kidney. Am J Physiol 276, 382-389.
Sironi L, Nobili E, Gianella A, Gelosa P, Tremoli E (2005): Anti-inflammatory properties of drugs acting on the renin-angiotensin system. Drugs Today 41, 609-622.
Solloway MJ, Robertson EJ (1999): Early embryonic lethality in Bmp5;Bmp7 double mutant mice suggests functional redundancy within the 60A subgroup. Development 126, 1753-1768.
Sterzel RB, Hartner A, Hilgers KF, Bressan GM (2001): Contribution of the mesangium to elastic strength and anchorage of the glomerular capillary tuft. Contrib Nephrol 131, 132-141.
Stewart RJ, Marsden PA (1995): Biologic control of the tumor necrosis factor and interleukin-1 signaling cascade. Am J Kidney Dis 25, 954-966.
Strutz F, Müller GA (1999): Interstitial pathomechanisms underlying progressive tubulointerstitial damage. Kidney Blood Press Res 22, 71-80.
Strutz F, Neilson EG (1994): The role of lymphocytes in the progression of interstitial disease. Kidney Int Suppl 45, S106-10.
Strutz F, Zeisberg M (2006): Renal fibroblasts and myofibroblasts in chronic kidney disease. J Am Soc Nephrol 17, 2992-2998.
Strutz F, Okada H, Lo CW, Danoff T, Carone RL, Tomaszewski JE, Neilson EG (1995): Identification and characterization of a fibroblast marker: FSP1. J Cell Biol 130, 393-405.
Strutz F, Zeisberg M, Renziehausen A, Raschke B, Becker V, van Kooten C, Müller G (2001): TGF-beta 1 induces proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2). Kidney Int 59, 579-592.
Strutz F, Zeisberg M, Ziyadeh FN, Yang CQ, Kalluri R, Müller GA, Neilson EG (2002): Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation. Kidney Int 61, 1714-1728.
Sugimoto H, Grahovac G, Zeisberg M, Kalluri R (2007): Renal fibrosis and glomerulosclerosis in a new mouse model of diabetic nephropathy and its regression by bone morphogenic protein-7 and advanced glycation end product inhibitors. Diabetes 56, 1825-1833.
Takahashi A, Alnemri ES, Lazebnik YA, Fernandes-Alnemri T, Litwack G, Moir RD, Goldman RD, Poirier GG, Kaufmann SH, Earnshaw WC (1996): Cleavage of lamin A by Mch2 alpha but not CPP32:
multiple interleukin 1 beta-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis. Proc Natl Acad Sci 93, 8395-8400.
Tamaki K, Souchelnytskyi S, Itoh S, Nakao A, Sampath K, Heldin CH, ten Dijke P (1998): Intracellular signaling of osteogenic protein-1 through Smad5 activation. J Cell Physiol 177, 355-363.
Thiery JP (2002): Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2, 442-454.
Thiery JP, Acloque H, Huang RY, Nieto MA (2009): Epithelial-mesenchymal transitions in development and disease. Cell 139, 871-890.
Thornberry NA, Lazebnik Y (1998): Caspases: enemies within. Science 281, 1312-1316.
Thrasos Therapeutics, 2000 Peel Street, Montreal, Kanada: www.thrasos.com. Abrufdatum 2011.
Tian Q, Miyazaki R, Ichiki T, Imayama I, Inanaga K, Ohtsubo H, Yano K, Takeda K, Sunagawa K (2009): Inhibition of tumor necrosis factor-alpha-induced interleukin-6 expression by telmisartan through cross-talk of peroxisome proliferator-activated receptor-gamma with nuclear factor kappaB and CCAAT/enhancer-binding protein-beta. Hypertension 53, 798-804.
Turgut F, Balogun RA, Abdel-Rahman EM (2010): Renin-angiotensin-aldosterone system blockade effects on the kidney in the elderly: benefits and limitations. Clin J Am Soc Nephrol 5, 1330-1339.
Urist MR (1965): Bone: formation by autoinduction. Science 150, 893-899.
Urist MR, DeLange RJ und Finerman GA (1983): Bone cell differentiation and growth factors. Science 220, 680-686.
Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 184, 39-51.
Vielhauer V, Berning E, Eis V, Kretzler M, Segerer S, Strutz F, Horuk R, Gröne HJ, Schlöndorff D, Anders HJ (2004): CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome. Kidney Int 66, 2264-2278.
Vukicevic S, Basic V, Rogic D, Basic N, Shih MS, Shepard A, Jin D, Dattatreyamurty B, Jones W, Dorai H, Ryan S, Griffiths D, Maliakal J, Jelic M, Pastorcic M, Stavljenic A, Sampath TK (1998):
Osteogenic protein-1 (bone morphogenetic protein-7) reduces severity of injury after ischemic acute renal failure in rat. J Clin Invest 102, 202-214.
Wang S, Chen Q, Simon TC, Strebeck F, Chaudhary L, Morrissey J, Liapis H, Klahr S, Hruska KA (2003): Bone morphogenic protein-7 (BMP-7), a novel therapy for diabetic nephropathy. Kidney Int 63, 2037-2049.
Wang SN, LaPage J, Hirschberg R (2001): Loss of tubular bone morphogenetic protein-7 in diabetic nephropathy. J Am Soc Nephrol 12, 2392–2399.
Wardle EN (1993): Cytokines: an overview. Eur J Med 2, 417-423.
Wetzel P, Haag J, Câmpean V, Goldschmeding R, Atalla A, Amann K, Aigner T (2006): Bone morphogenetic protein-7 expression and activity in the human adult normal kidney is predominantly localized to the distal nephron. Kidney Int 70, 717-723.
Wiederkehr M, Toto R, Fenves AZ und Ram CV (2005): Hypertension and the kidney. Semin Nephrol 25, 236-45.
Wittwer CT, Hermann MG, Moss AA, Rasmussen RP (1997): Continuous fluorescence monitoring of rapid cycle DNA amplification. Biotechniques 22, 130-131.
Wolf G, Ritz E (2005): Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications. Kidney Int 67, 799-812.
Wolf G, Kalluri R, Ziyadeh FN, Neilson EG und Stahl RA (1999): Angiotensin II induces alpha3(IV) collagen expression in cultured murine proximal tubular cells. Proc Assoc Am Physicians 111, 357-364.
Xu Y, Wan J, Jiang D, Wu X (2009): BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition in human renal proximal tubular epithelial cells. J Nephrol 22, 403-410.
Yanagita M (2007): Balance between bone morphogenetic proteins and their antagonists in kidney injury. Ther Apher Dial 1, 38-43.
Yang J, Weinberg RA (2008): Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 14, 818-829. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 13, 952-61.
Zeisberg M (2006): Bone morphogenic protein-7 and the kidney: current concepts and open questions. Nephrol Dial Transplant 21, 568-573.
Zeisberg M, Duffield JS (2010): Resolved: EMT produces fibroblasts in the kidney. J Am Soc Nephrol 21, 1247-1253.
Zeisberg M, Kalluri R (2004a): The role of epithelial-to-mesenchymal transition in renal fibrosis. J Mol Med 82, 175-181.
Zeisberg M, Kalluri R (2004b): Experimental strategies to reverse chronic renal disease. Blood Purif 22, 440-445.
Zeisberg M, Neilson EG (2009): Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 119, 1429-1437.
Zeisberg M, Neilson EG (2010): Mechanisms of tubulointerstitial fibrosis. J Am Soc Nephrol 21, 1819-1834.
Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, Strutz F, Kalluri R (2003): BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 9, 964-968.
Zeisberg M, Müller GA, Kalluri R (2004): Are there endogenous molecules that protect kidneys from injury? The case for bone morphogenic protein-7 (BMP-7). Nephrol Dial Transplant 19, 759-761.
Zeisberg M, Shah AA, Kalluri R (2005): Bone morphogenic protein-7 induces mesenchymal to epithelial transition in adult renal fibroblasts and facilitates regeneration of injured kidney. J Biol Chem 280, 8094-8100.
Zhao GQ (2003): Consequences of knocking out BMP signaling in the mouse. Genesis 35, 43-56.
Zhong J, Guo D, Chen CB, Wang W, Schuster M, Loibner H, Penninger JM, Scholey JW, Kassiri Z, Oudit GY (2010): Prevention of Angiotensin II-Mediated Renal Oxidative Stress, Inflammation, and Fibrosis by Angiotensin-Converting Enzyme 2. Hypertension 57, 314-322.
Zhou X, Sasaki H, Lowe L, Hogan BL, Kuehn MR (1993): Nodal is a novel TGF-beta-like gene expressed in the mouse node during gastrulation. Nature 361, 543-547.
Zoja C, Donadelli R, Colleoni S, Figliuzzi M, Bonazzola S, Morigi M, Remuzzi G (1998): Protein
Zoja C, Donadelli R, Colleoni S, Figliuzzi M, Bonazzola S, Morigi M, Remuzzi G (1998): Protein